0001615774-18-011318.txt : 20181025 0001615774-18-011318.hdr.sgml : 20181025 20181025161127 ACCESSION NUMBER: 0001615774-18-011318 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181025 DATE AS OF CHANGE: 20181025 EFFECTIVENESS DATE: 20181025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tivorsan Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001705703 IRS NUMBER: 770702642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1217 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324387 FILM NUMBER: 181139020 BUSINESS ADDRESS: STREET 1: 3 DAVOL SQUARE, A301 CITY: PROVIDENCE STATE: RI ZIP: 02903 BUSINESS PHONE: 310-424-1986 MAIL ADDRESS: STREET 1: 2049 CENTURY PARK EAST, SUITE 320 CITY: LOS ANGELES STATE: CA ZIP: 90067 D 1 primary_doc.xml X0708 D LIVE 0001705703 Tivorsan Pharmaceuticals, Inc. 2049 CENTURY PARK EAST SUITE 320 LOS ANGELES CA CALIFORNIA 90067 310-424-1999 DELAWARE None None Corporation true Michael Meyers 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 Executive Officer John Nicholson 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 Director Justin Fallon 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 Director Joel Braunstein 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 Director Jay Venkatesan 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 Director James Connolly 2049 Century Park East Suite 320 Los Angeles CA CALIFORNIA 90067 Director Pharmaceuticals Decline to Disclose 06b false 2017-03-17 false true false 10000 T.R. Winston & Company, LLC 10571 None None 2049 CENTURY PARK EAST SUITE 320 LOS ANGELES CA CALIFORNIA 90067 CA CALIFORNIA DE DELAWARE HI HAWAII KS KANSAS MA MASSACHUSETTS NY NEW YORK PA PENNSYLVANIA TX TEXAS VA VIRGINIA false 4474000 4474000 0 false 32 313180 0 0 false Tivorsan Pharmaceuticals, Inc. /s/ Michael Meyers Michael Meyers Chief Executive Officer 2018-10-25